The prevalence, genotype and antimicrobial susceptibility of high-and low-level mupirocin resistant methicillin-resistant Staphylococcus aureus

Annals of Dermatology

Volumn 24, Issue 1, 2012, Pages 32-38

  Park, Se Young ^a   Kim, Shin Moo ^b   Park, Seok Don ^a,c  

^a Wonkwang University Hospital   (South Korea)

^b Wonkwang Health Science University   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

Author keywords

Antimicrobial susceptibility; MRSA; Mupirocin; Pulsed field gel electrophoresis

Indexed keywords

EID: 84863142606     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.1.32     Document Type: Article

References (26)

1. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 1985;27:495-498. (Pubitemid 15097646)
2. Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D, et al; Canadian Nosocomial Infection Surveillance Program. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007;51:3880-3886. (Pubitemid 350057784)
3. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41:11-18. (Pubitemid 28064245)
4. Yun HJ, Lee SW, Yoon GM, Kim SY, Choi S, Lee YS, et al. Prevalence and mechanisms of low-and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob Chemother 2003;51:619-623. (Pubitemid 36336155)
5. Yoo JI, Shin ES, Cha JO, Lee JK, Jung YH, Lee KM, et al. Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea. Antimicrob Agents Chemother 2006;50:365-367. (Pubitemid 43042948)
6. Yang JA, Park DW, Sohn JW, Yang IS, Kim KH, Kim MJ. Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance. J Korean Med Sci 2006;21:827-832.
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. Wayne: Clinical and Laboratory Standards Institute, 2009.
8. Lee HK, Lee EJ, Pahk YJ, Kim BK, Kang MW, Shim SI. Relationship between the level of methicillin resistance and mecA, mecI, femA genes genes in Staphylococci. Korean J Infect Dis 1998;30:36-44.
9. Yokoyama T. Study on mec gene in methicillin-resistant staphylococci. Kansenshogaku Zasshi 1993;67:1203-1210.
10. Ramsey MA, Bradley SF, Kauffman CA, Morton TM. Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother 1996;40:2820-2823. (Pubitemid 26404351)
11. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE, et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 2003;41:1574-1585. (Pubitemid 36428107)
12. Heyndrickx M, Vandemeulebroecke K, Scheldeman P, Kersters K, de Vos P, Logan NA, et al. A polyphasic reassessment of the genus Paenibacillus, reclassification of Bacillus lautus (Nakamura 1984) as Paenibacillus lautus comb. nov. and of Bacillus peoriae (Montefusco et al. 1993) as Paenibacillus peoriae comb. nov., and emended descriptions of P. lautus and of P. peoriae. Int J Syst Bacteriol 1996;46:988-1003. (Pubitemid 26339225)
13. Sokal RR, Michener CD. A statistical method for evaluating systematic relationships. University of Kansas Scientific Bulletin 1958;28:1409-1438.
14. Rahman M, Noble WC, Cookson B, Baird D, Coia J. Mupirocinresistant staphylococcus aureus. Lancet 1987;330:387-388.
15. Conly JM, Vas S. Increasing mupirocin resistance of Staphylococcus aureus in CAPD-should it continue to be used as prophylaxis? Perit Dial Int 2002;22:649-652. (Pubitemid 36131493)
16. Pérez-Fontán M, Rosales M, Rodríguez-Carmona A, Falcón TG, Valdés F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337-341. (Pubitemid 34174256)
17. Wise R, Johnson J. Mupirocin resistance. Lancet 1991;338(8766):578.
18. Lee HJ, Suh JT, Kim YS, Lenz W, Bierbaum G, Schaal KP. Typing and antimicrobial susceptibilities of methicillin resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. J Korean Med Sci 2001;16:381-385. (Pubitemid 33741334)
19. Redhead RJ, Lamb YJ, Rowsell RB. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. Br J Clin Pract 1991;45:252-254.
20. Janssen DA, Zarins LT, Schaberg DR, Bradley SF, Terpenning MS, Kauffman CA. Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993;37:2003-2006. (Pubitemid 23265570)
21. Chaves F, García-Martínez J, de Miguel S, Otero JR. Molecular characterization of resistance to mupirocin in methicillinsusceptible and-resistant isolates of Staphylococcus aureus from nasal samples. J Clin Microbiol 2004;42:822-824. (Pubitemid 38222670)
22. Thomas DG, Wilson JM, Day MJ, Russell AD. Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro. J Appl Microbiol 1999;86:715-722. (Pubitemid 29180547)
23. Bastos MC, Mondino PJ, Azevedo ML, Santos KR, Giambiagide Marval M. Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin. Eur J Clin Microbiol Infect Dis 1999;18:393-398. (Pubitemid 29531202)
24. Kim SM, Lee DC, Park SD, Kim BS, Kim JK, Choi MR, et al. Genotype, coagulase type and antimicrobial susceptibility of methicillin-resistant staphylococcus aureus isolated from dermatology patients and Healthy Individuals in Korea. J Bacteriol Virol 2009;39:307-316.
25. Maple PA, Hamilton-Miller JM, Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1992;29:661-668.
26. Riley TV, Carson CF, Bowman RA, Mulgrave L, Golledge CL, Pearman JW, et al. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1994;161:397-398. (Pubitemid 24286600)